1. Home
  2. CLNN vs EUDA Comparison

CLNN vs EUDA Comparison

Compare CLNN & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • EUDA
  • Stock Information
  • Founded
  • CLNN 2012
  • EUDA 2021
  • Country
  • CLNN United States
  • EUDA Singapore
  • Employees
  • CLNN N/A
  • EUDA N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • EUDA Blank Checks
  • Sector
  • CLNN Health Care
  • EUDA Finance
  • Exchange
  • CLNN Nasdaq
  • EUDA Nasdaq
  • Market Cap
  • CLNN 60.3M
  • EUDA 68.7M
  • IPO Year
  • CLNN N/A
  • EUDA N/A
  • Fundamental
  • Price
  • CLNN $8.48
  • EUDA $2.35
  • Analyst Decision
  • CLNN Strong Buy
  • EUDA
  • Analyst Count
  • CLNN 6
  • EUDA 0
  • Target Price
  • CLNN $32.67
  • EUDA N/A
  • AVG Volume (30 Days)
  • CLNN 146.3K
  • EUDA 84.3K
  • Earning Date
  • CLNN 11-12-2025
  • EUDA 01-01-0001
  • Dividend Yield
  • CLNN N/A
  • EUDA N/A
  • EPS Growth
  • CLNN N/A
  • EUDA N/A
  • EPS
  • CLNN N/A
  • EUDA 0.01
  • Revenue
  • CLNN $286,000.00
  • EUDA $5,160,280.00
  • Revenue This Year
  • CLNN N/A
  • EUDA $137.25
  • Revenue Next Year
  • CLNN $1,363.77
  • EUDA $361.43
  • P/E Ratio
  • CLNN N/A
  • EUDA $339.97
  • Revenue Growth
  • CLNN N/A
  • EUDA 83.73
  • 52 Week Low
  • CLNN $2.28
  • EUDA $1.03
  • 52 Week High
  • CLNN $11.06
  • EUDA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 54.52
  • EUDA 48.35
  • Support Level
  • CLNN $7.66
  • EUDA $2.96
  • Resistance Level
  • CLNN $8.58
  • EUDA $3.59
  • Average True Range (ATR)
  • CLNN 0.93
  • EUDA 0.51
  • MACD
  • CLNN -0.17
  • EUDA -0.09
  • Stochastic Oscillator
  • CLNN 26.22
  • EUDA 25.90

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.

Share on Social Networks: